Ezra writes about identity, health systems, aesthetics and the pressure of being legible to institutions and to algorithms.
Body
Mindbloom, Joyous, Better U and Innerwell publish plenty about starting treatment. Their public documentation is much less concrete about discharge, referrals and life after payment.
Ezra Kimani · 8 min read
Body
The Rhino packet sells discretion in a single dose. Its real product is a shortcut around ordinary care, built on supplement rules that let certainty appear long before evidence does.
Ezra Kimani · 8 min read
Body
A directory badge can mean a therapist is in-network, files out-of-network claims or merely gives you a receipt. Here is how to tell before the first bill arrives.
Ezra Kimani · 8 min read
Body
A familiar six-question ADHD screener now doubles as the front door to telehealth marketing. The score may be useful, but the funnel around it has another job.
Ezra Kimani · 8 min read
Body
I challenged a wellness chatbot after a patronizing breathing exercise. Its apology did not repair the exchange. It quietly restarted the intervention.
Ezra Kimani · 8 min read
Body
State bans and federal enforcement can empty a shelf. They cannot safely end physical dependence on tianeptine, an unapproved drug sold through the supplement market.
Ezra Kimani · 8 min read
Body
Fentanyl and xylazine strips can look interchangeable. Their thresholds, blind spots and instructions are not, and one negative line answers far less than the packaging suggests.
Ezra Kimani · 8 min read
Body
BetterHelp’s crisis notice exposes the limit built into app-based therapy: the subscription can organize care, but it cannot promise a clinician when distress becomes urgent.
Ezra Kimani · 8 min read
Body
Packaging, moisture, heat and expiration can undermine a drug-testing strip before it touches a sample. This checklist identifies obvious failures, not hidden ones.
Ezra Kimani · 8 min read
Body
A strip can detect fentanyl in the sample that reaches it. It cannot tell you what sits elsewhere in the bag, how potent the drug is, or whether something else dangerous is present.
Ezra Kimani · 8 min read
Body
A strip can flag xylazine in one prepared sample. Dilution, uneven mixtures, detection limits and everything the strip cannot see make a negative result much narrower than reassurance.
Ezra Kimani · 8 min read
Body
The strip reads the water it touches, not the whole pill by default. The sampling work that makes a result meaningful is often the part public-health cards compress or omit.
Ezra Kimani · 8 min read
Body
The strip reads the liquid it touches, not the whole supply. Uneven distribution and sample preparation turn a clean-looking result into narrower evidence than many instruction cards admit.
Ezra Kimani · 7 min read
Body
The strip looks definitive. The preparation is not. Guidance diverges before the test touches water, leaving users to resolve sampling and dilution under pressure.
Ezra Kimani · 8 min read
Body
At-home strips reduce uncertainty about a specific drug in a specific portion. Their neat lines can also hide sampling errors, cross-reactivity and damage from bad storage.
Ezra Kimani · 8 min read
Body
Compounded GLP-1 telehealth funnels turn a questionnaire into evidence of care. The same interface can screen patients, secure consent, and prepare the next subscription charge.
Ezra Kimani · 8 min read
Body
A strip can flag fentanyl in a prepared sample. In a dark, crowded restroom, preparation and interpretation matter as much as the small piece of paper.
Ezra Kimani · 8 min read
Body
Photo badges confirm a face completed a prompt. ID badges go further, but none of the major apps’ checks certify that a match is trustworthy or safe to meet.
Ezra Kimani · 8 min read